NASDAQ:KPRX | Cash Flow Statement | KIORA PHARMACEUTICALS INC

Complete source-backed cash-flow history.

Available history
2014-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.08M
2026-03-31-$2.42M$10,563.00-$3.16M$5,018.00$5.4M-$842.00
2025-12-31-$6.52M$10,508.00-$2.18M$78,163.00$5.35M$296.00
2025-09-30$26,806.00
2025-06-30-$2.15M
2025-03-31-$2.19M$318.00-$2.7M$0.00$2.67M$0.00
2024-12-31-$4.22M$5,912.00-$2.25M-$45,031.00$482,683.00$0.00
2024-09-30-$3.41M
2024-06-30-$2.22M
2024-03-31$13.45M$4,869.00$13.62M$0.00$15.25M
2023-12-31-$2.27M$7,935.00-$2.58M$0.00$0.00-$486,421.00
2023-09-30-$5.76M
2023-06-30-$2.61M
2023-03-31-$1.87M$10,078.00-$3.07M$0.00$513,175.00
2022-12-31-$2.5M$10,285.00-$2.13M$0.00$3.24M
2022-09-30-$5.12M
2022-06-30-$2.4M
2022-03-31-$3.57M$10,773.00-$2.83M$6,375.00$0.00
2021-12-31-$6.18M$11,036.00-$2.92M$0.00-$93,155.00-$212,282.00
2021-09-30-$3.03M
2021-06-30-$2.54M
2021-03-31-$2.01M$10,599.00-$2.57M$58,119.00-$58,119.00$8.04M
2020-12-31-$2.42M$9,056.00-$1.71M$218,000.00
2020-09-30-$2.01M
2020-06-30-$1.72M
2020-03-31-$1.95M$7,067.00-$2.4M$4.5M
2019-12-31-$2.7M$12,918.00-$2.59M$0.00$0.00$3.91M
2019-09-30-$3.43M
2019-06-30-$1.84M
2019-03-31$870,809.00$12,918.00-$2.15M-$1,572.00
2018-12-31-$2.53M$12,919.00-$2M$0.00$0.00$110,112.00
2018-09-30-$3.12M
2018-06-30-$2.78M
2018-03-31-$2.38M$7,966.00-$4.11M-$43,555.00
2017-12-31-$2.83M$5,680.00-$1.45M$36,999.00-$36,999.00$50,936.00
2017-09-30-$4.14M
2017-06-30-$3.33M
2017-03-31-$2.92M$4,536.00-$18,601.00$1.82M
2016-12-31-$3.7M$4,536.00-$2.05M$25,000.00-$2,863.00
2016-09-30-$3.38M
2016-06-30-$3.82M
2016-03-31-$2.44M$84.00-$1.35M
2015-12-31-$2.69M$231.00-$1.55M
2015-09-30-$1.36M
2015-06-30-$1.54M
2015-03-31-$2.8M$342.00-$1.77M
2014-12-31-$351,940.00$432.00-$436,135.00
2014-09-30$350,258.00
2014-06-30-$646,934.00
2014-03-31-$902,892.00$600.00-$431,098.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$10.84M$24,801.00-$9.96M$110,789.00$14.43M$265,655.00
2024-12-31$3.59M$19,205.00$8.56M$6,256.00-$22.66M$15.5M
2023-12-31-$12.51M$51,798.00-$9.56M$0.00$0.00$5.97M
2022-12-31-$13.58M$41,609.00-$10.43M$0.00$6,375.00$8.62M
2021-12-31-$13.77M$45,296.00-$10.68M$63,865.00-$157,020.00$17.58M
2020-12-31-$8.09M$33,399.00-$7.32M$20,077.00-$244,438.00$5M
2019-12-31-$7.1M$51,672.00-$8.15M$0.00$0.00$3.92M
2018-12-31-$10.81M$38,483.00-$10.84M$20,000.00-$270,000.00$11.3M
2017-12-31-$13.22M$19,288.00-$6.47M$36,999.00-$36,999.00$10.67M
2016-12-31-$13.34M$5,185.00-$8.41M$0.00$174,746.00$3.5M
2015-12-31-$8.39M$1,257.00-$4.46M
2014-12-31-$1.55M$1,724.00-$950,617.00